Protocol approach 1: immune rebalancing (thymosin alpha-1 plus KPV) Goal: Restore regulatory immune function while reducing inflammatory signaling Components: Thymosin alpha-1: 1.6 mg subcutaneously twice per week (promotes Treg expansion, modulates dendritic cells) KPV: 200-500 mcg daily, orally or subcutaneously (inhibits NF-kB, reduces TNF-alpha and IL-6) Rationale: Thymosin alpha-1 works at the cellular level to rebuild the regulatory arm of the immune system, while KPV addresses the inflammatory signaling that drives acute symptoms
Acute water ingestion increases arterial blood pressure in hypertensive and normotensive subjects
Vitamin B12 can help prevent premature greying
For a deeper primer on the blends identity and rationale, see our explainer on what the KLOW peptide blend is, and for the outcomes literature see KLOW benefits: what research shows
If your cat does well on that and is still showing signs of pain, it can be increased to 1/2 tab BID
I am no experiencing any energy dips or muscle mass loss